BioCentury
ARTICLE | Financial News

Morphochem raises EUR40.7 million

August 2, 2000 7:00 AM UTC

Morphochem (Munich, Germany) raised EUR40.7 million ($37.5 million) through a private placement. The company, which specializes in protein-protein interaction and proteomics drug discovery, said the round included existing investors Techno Venture Management; Alta Partners; IKB Venture Capital; Alta Berkeley; Domain Associates; and 3i Bioscience Investment Trust. New investors are Merlin BioSciences; Nomura; Julius Bar; West LB; and Viscardi. Morphochem said the placement was two times oversubscribed. ...